Literature DB >> 21969119

The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.

Lucian R Chirieac, Geraldine S Pinkus, Jack L Pinkus, John Godleski, David J Sugarbaker, Joseph M Corson.   

Abstract

The immunohistochemical characteristics of epithelioid malignant mesothelioma are well described. However, immunohistochemical analyses of sarcomatoid mesothelioma, the less common type, are limited and its distinction from other tumors of the chest wall, lung and pleura is often problematic. We evaluated 24 patients with pleural sarcomatoid mesothelioma who had surgery (12 extrapleural pneumonectomies, 9 pleurectomies and 3 large biopsies) between 1989 and 2005. Clinicopathologic features and demographic data were recorded. We describe immunohistochemical results for 10 antibodies: AE1/AE3, CAM5.2 and MNF-116 keratins, calretinin, WT-1 protein, bcl-2, CD34, desmin, D2-40 and podoplanin. The patients were 23 men and one woman with a median age at diagnosis of 64.7 years (range 47 to 76). Tumor cells were positive for the keratin proteins AE1/AE3 in 18/24 cases, CAM 5.2 in 23/24 cases and MNF-116 in 21/21 cases. Calretinin was positive in 6/24 cases, WT-1 (nuclear) in 8/24 cases, bcl-2 in 0/24 cases, CD34 in 0/24 cases, desmin in 0/24 cases, D2-40 in 24/24 cases and podoplanin in 24/24 cases. This panel of antibodies may be helpful in establishing a pathologic diagnosis of sarcomatoid mesothelioma. In our study, D2-40 and podoplanin are highly sensitive immunohistochemical markers for sarcomatoid mesothelioma. Additional studies are required to define their role in the differential diagnosis of other spindle cell tumors.

Entities:  

Year:  2010        PMID: 21969119      PMCID: PMC3180102     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  48 in total

Review 1.  Spindle cell tumors of the pleura: differential diagnosis.

Authors:  Monica Rdzanek; Raoul Fresco; Harvey I Pass; Michele Carbone
Journal:  Semin Diagn Pathol       Date:  2006-02       Impact factor: 3.464

2.  Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases.

Authors:  Saul Suster; Cesar A Moran
Journal:  Am J Surg Pathol       Date:  2005-05       Impact factor: 6.394

3.  Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.

Authors:  R L Attanoos; S D Dojcinov; R Webb; A R Gibbs
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

4.  The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval.

Authors:  J R Riera; C Astengo-Osuna; J A Longmate; H Battifora
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

5.  Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.

Authors:  M Miettinen; J Limon; A Niezabitowski; J Lasota
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

6.  Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.

Authors:  D R Lucas; H I Pass; S K Madan; N V Adsay; A Wali; P Tabaczka; F Lonardo
Journal:  Histopathology       Date:  2003-03       Impact factor: 5.087

Review 7.  Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.

Authors:  Saul Suster; Cesar A Moran
Journal:  Adv Anat Pathol       Date:  2006-11       Impact factor: 3.875

8.  Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.

Authors:  Diana M Padgett; Helen P Cathro; Mark R Wick; Stacey E Mills
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

9.  Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.

Authors:  S Suster; C Fisher; C A Moran
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

10.  Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.

Authors:  Brock C Christensen; John J Godleski; Carmen J Marsit; E A Houseman; Cristina Y Lopez-Fagundo; Jennifer L Longacker; Raphael Bueno; David J Sugarbaker; Heather H Nelson; Karl T Kelsey
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

View more
  10 in total

1.  The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats.

Authors:  Susanne Rittinghausen; Anja Hackbarth; Otto Creutzenberg; Heinrich Ernst; Uwe Heinrich; Albrecht Leonhardt; Dirk Schaudien
Journal:  Part Fibre Toxicol       Date:  2014-11-20       Impact factor: 9.400

2.  Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Authors:  Amanda L Hudson; Chris Weir; Elizabeth Moon; Rozelle Harvie; Sonja Klebe; Stephen J Clarke; Nick Pavlakis; Viive M Howell
Journal:  Sci Rep       Date:  2014-08-21       Impact factor: 4.379

3.  Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.

Authors:  Yuuki Ohara; Atsushi Enomoto; Yuta Tsuyuki; Kotaro Sato; Tadashi Iida; Hiroki Kobayashi; Yasuyuki Mizutani; Yuki Miyai; Akitoshi Hara; Shinji Mii; Jun Suzuki; Kyoko Yamashita; Fumiya Ito; Yashiro Motooka; Nobuaki Misawa; Takayuki Fukui; Koji Kawaguchi; Kohei Yokoi; Shinya Toyokuni
Journal:  Oncol Rep       Date:  2020-07-03       Impact factor: 3.906

4.  Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma.

Authors:  Takanori Ito; Kohei Fujita; Misato Okamura; Yoshiaki Okuno; Zentaro Saito; Osamu Kanai; Koichi Nakatani; Koki Moriyoshi; Tadashi Mio
Journal:  Respir Med Case Rep       Date:  2020-08-28

5.  Sarcomatoid mesothelioma of tunica vaginalis testis in the right scrotum of a dog.

Authors:  Nguyen V Son; James K Chambers; Takanori Shiga; Takuya E Kishimoto; Shotaro Kikuhara; Kohei Saeki; Reina Fujiwara; Masaya Tsuboi; Ryohei Nishimura; Kazuyuki Uchida; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2018-05-23       Impact factor: 1.267

6.  Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma.

Authors:  Hitomi Sudo; Atsushi B Tsuji; Aya Sugyo; Tsuneo Saga; Mika K Kaneko; Yukinari Kato; Tatsuya Higashi
Journal:  Cancer Sci       Date:  2019-03-12       Impact factor: 6.716

Review 7.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

8.  Peritoneal Mesothelioma: An Unusual Cause of High-Protein Ascites.

Authors:  Matthew Kaspar
Journal:  ACG Case Rep J       Date:  2015-10-09

9.  Diagnostic value of D2-40 immunostaining for malignant mesothelioma: a meta-analysis.

Authors:  Chao He; Bo Wang; Chun Wan; Ting Yang; Yongchun Shen
Journal:  Oncotarget       Date:  2017-07-06

10.  The Role of Immunohistochemistry Studies in Distinguishing Malignant Mesothelioma from Metastatic Lung Carcinoma in Malignant Pleural Effusion.

Authors:  Monireh Halimi; Samad BeheshtiRouy; Davood Salehi; Seyed Ziaeddin Rasihashemi
Journal:  Iran J Pathol       Date:  2019-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.